Literature DB >> 9274405

Dry eye and Meige's syndrome.

K Tsubota1, T Fujihara, M Kaido, A Mori, M Mimura, M Kato.   

Abstract

AIMS: To determine the relation between dry eye and Meige's syndrome.
METHODS: 325 patients with dry eye were divided into those responsive to topical and other forms of treatment (n = 276) and those who were not (n = 49). A neuropsychiatric examination was performed to check for Meige's syndrome in the latter group.
RESULTS: Twenty eight (57%) of the treatment unresponsive patients were diagnosed with Meige's syndrome.
CONCLUSIONS: There is a subgroup of patients with dry eye who do not respond to simple therapy. More than half of these patients have Meige's syndrome and need psychiatric, as well as ophthalmic, care.

Entities:  

Mesh:

Year:  1997        PMID: 9274405      PMCID: PMC1722218          DOI: 10.1136/bjo.81.6.439

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  The importance of the Schirmer test with nasal stimulation.

Authors:  K Tsubota
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

2.  Practical double vital staining for ocular surface evaluation.

Authors:  I Toda; K Tsubota
Journal:  Cornea       Date:  1993-07       Impact factor: 2.651

Review 3.  Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.

Authors:  E Tolosa; M J Martí
Journal:  Adv Neurol       Date:  1988

Review 4.  Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.

Authors:  J Jankovic
Journal:  Adv Neurol       Date:  1988

5.  Dry eyes and video display terminals.

Authors:  K Tsubota; K Nakamori
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

Review 6.  New approaches to dry-eye therapy.

Authors:  K Tsubota
Journal:  Int Ophthalmol Clin       Date:  1994

7.  Conjunctival cytologic features of primary Sjögren's syndrome.

Authors:  S C Pflugfelder; A J Huang; W Feuer; P T Chuchovski; I C Pereira; S C Tseng
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

Review 8.  Facial dystonia, essential blepharospasm and hemifacial spasm.

Authors:  J B Holds; G L White; S M Thiese; R L Anderson
Journal:  Am Fam Physician       Date:  1991-06       Impact factor: 3.292

9.  Dermatochalasis and dry eye.

Authors:  S D Vold; R P Carroll; J D Nelson
Journal:  Am J Ophthalmol       Date:  1993-02-15       Impact factor: 5.258

Review 10.  Essential blepharospasm and related dystonias.

Authors:  D R Jordan; J R Patrinely; R L Anderson; S M Thiese
Journal:  Surv Ophthalmol       Date:  1989 Sep-Oct       Impact factor: 6.048

View more
  6 in total

Review 1.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

2.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

3.  A Case Report of Psychoactive Drugs Aggravating and Alleviating Meige Syndrome.

Authors:  Shimiao Zhao; Yingchun Zhang; Luoyi Xu; Lili Wei; Wei Chen
Journal:  Shanghai Arch Psychiatry       Date:  2016-08-25

4.  Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.

Authors:  Supharat Jariyakosol; Lita Uthaithammarat; Nattakarn Chatwichaikul; Ngamjit Kasetsuwan; Yuda Chongpison
Journal:  Clin Ophthalmol       Date:  2021-04-28

5.  Refractory dry eye disease associated with Meige's syndrome induced by long-term use of an atypical antipsychotic.

Authors:  Ji Eun Kim; Ji Won Jung
Journal:  BMC Ophthalmol       Date:  2020-12-02       Impact factor: 2.209

6.  The environmental epidemiology of primary dystonia.

Authors:  Giovanni Defazio; Angelo F Gigante
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.